Skip to article
Astra

Pediatric Emergency Medicine

Febrile Infant Workup

Evaluate well-appearing febrile infants by age, urinalysis, blood culture, and inflammatory markers; reserve lumbar puncture, empiric antibiotics, and hospitalization for higher-risk profiles while preserving reliable follow-up for selected older low-risk infants.

Clinical question: How should U.S. clinicians evaluate and disposition a well-appearing febrile infant using age, urine testing, cultures, and inflammatory markers?

First decision

Identify infants who require a full sepsis-directed evaluation

Age and appearance determine whether risk stratification is appropriate.

Use age-specific risk stratification only after confirming that the infant is well appearing and has fever without an apparent source. The 2021 AAP clinical practice guideline applies to term infants born at 37 weeks' gestation or later who are 8 to 60 days old; preterm infants are outside that guideline population and require individualized evaluation. publications aapRate of Urinary Tract Infections, Bacteremia, and Meningitis in Preterm and Term Infants | Pediatrics | American Academy of Pediatrics

Do not downgrade a documented home fever simply because the infant is afebrile in the emergency department. Infants with reported fever at home have a non-negligible UTI risk and a similar invasive bacterial infection prevalence compared with infants febrile on presentation; manage them with the same age-based pathway. acepAsk the Expert-Management of the Well-Appearing Febrile Young Infant: Integrating the AAP Guideline into Practice | Pediatric Emergency Medicine

Separate invasive bacterial infection from UTI when making procedural and disposition decisions. Among well-appearing febrile infants younger than 60 days, reported rates are approximately 5% to 17% for UTI, 1% to 2% for bacteremia, and 0.2% to 1% for meningitis. publications aapRate of Urinary Tract Infections, Bacteremia, and Meningitis in Preterm and Term Infants | Pediatrics | American Academy of Pediatrics

Population boundaries that change use of the standard febrile-infant pathway. publications aapRate of Urinary Tract Infections, Bacteremia, and Meningitis in Preterm and Term Infants | Pediatrics | American Academy of PediatricsacepAsk the Expert-Management of the Well-Appearing Febrile Young Infant: Integrating the AAP Guideline into Practice | Pediatric Emergency Medicine
Clinical featureWorkup implication
Well appearing, term, 8-60 days, no sourceUse age-stratified urine, blood, inflammatory-marker, and cerebrospinal-fluid decisions. publications aapRate of Urinary Tract Infections, Bacteremia, and Meningitis in Preterm and Term Infants | Pediatrics | American Academy of Pediatrics
Preterm birthAAP pathway does not apply; individualize evaluation because the evidence base was derived primarily in term infants. publications aapRate of Urinary Tract Infections, Bacteremia, and Meningitis in Preterm and Term Infants | Pediatrics | American Academy of Pediatrics
Fever measured only at homeUse the same approach as for fever measured in the emergency department. acepAsk the Expert-Management of the Well-Appearing Febrile Young Infant: Integrating the AAP Guideline into Practice | Pediatric Emergency Medicine
Ill appearanceDo not use low-risk outpatient criteria; pursue urgent evaluation for bacteremia and meningitis. BMJDisparities and implicit bias in the management of low- risk febrile ...publications aapRate of Urinary Tract Infections, Bacteremia, and Meningitis in Preterm and Term Infants | Pediatrics | American Academy of Pediatrics

Core tests

Obtain urine testing and age-appropriate blood evaluation

Urine results and inflammatory markers drive the next procedural decision.

Obtain urinalysis and urine culture as the foundational bacterial assessment because UTI is the dominant serious bacterial infection in this population. A normal urinalysis is a key component of low-risk classification; leukocytes on dipstick or leukocyturia moves the infant out of low-risk pathways used for outpatient management. NEJMSuccessful Outpatient Management of Febrile Infants Without a Lumbar Puncture or Antibiotics | NEJM ClinicianPubMedOutpatient management of selected young febrile infants without antibiotics - PubMed

For infants being evaluated for invasive bacterial infection, obtain a CBC with ANC, blood culture, and inflammatory markers. Modern prediction strategies use urine and blood testing to identify infants aged 22 to 60 days at substantially lower risk for bacteremia and bacterial meningitis, but risk is not zero even when screening results are normal. BMJDisparities and implicit bias in the management of low- risk febrile ...publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of Pediatrics

Use procalcitonin preferentially when available because it has better discrimination for invasive bacterial infection than CRP, WBC count, or ANC in young febrile infants. Published low-risk procalcitonin cutoffs vary from 0.12 to 1.71 ng/mL; therefore, interpret the value within a validated institutional pathway rather than substituting an arbitrary standalone threshold. PubMedUse of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days - PMC

Inflammatory-marker approaches for febrile infants 8 to 60 days. publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of PediatricsPubMedUse of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days - PMCacepAsk the Expert-Management of the Well-Appearing Febrile Young ...
Testing contextReassuring patternResult that changes management
Procalcitonin availableUse a validated pathway that incorporates procalcitonin with urine and other clinical criteria; no single universal low-risk cutoff is established. PubMedUse of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days - PMCElevated procalcitonin or a nonreassuring urine result should prompt higher-risk evaluation rather than outpatient designation. PubMedUse of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days - PMCPubMedOutpatient management of selected young febrile infants without antibiotics - PubMed
Procalcitonin unavailableTemperature 38.5°C or lower, ANC 5,200/mm3 or lower, and CRP 20 mg/L or lower. publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of PediatricsacepAsk the Expert-Management of the Well-Appearing Febrile Young ...Temperature greater than 38.5°C, ANC greater than 5,200/mm3, or CRP 20 mg/L or greater is abnormal and should remove the infant from the reassuring-marker group. publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of PediatricsacepAsk the Expert-Management of the Well-Appearing Febrile Young ...
Recent antibioticsNo validated reassuring marker combination. acepAsk the Expert-Management of the Well-Appearing Febrile Young ...Do not rely on standard prediction-rule cutoffs alone. acepAsk the Expert-Management of the Well-Appearing Febrile Young ...

When procalcitonin is unavailable

Use the AAP-recommended combination of maximum temperature, ANC, and CRP. Abnormal values are temperature greater than 38.5°C, ANC greater than 5,200/mm3, and CRP 20 mg/L or greater. In a single-center evaluation, the low-risk combination of temperature 38.5°C or lower, ANC 5,200/mm3 or lower, and CRP 20 mg/L or lower had 100% sensitivity for invasive bacterial infection, with 46% specificity. publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of PediatricsacepAsk the Expert-Management of the Well-Appearing Febrile Young ...

Lumbar puncture

Use age and risk markers to decide on cerebrospinal fluid testing

The central tradeoff is avoiding unnecessary lumbar puncture without missing meningitis.

For the youngest eligible infants, maintain a low threshold for lumbar puncture because invasive bacterial infection risk declines over the first weeks of life and evidence-based risk stratification is most useful in older infants. The outpatient literature does not recommend outpatient management for infants younger than 28 days, whereas selected infants older than 21 days have been studied after short emergency observation. ScienceDirectEvaluation of the febrile infant younger than 3 months of age with no source of infection - ScienceDirectPubMedOutpatient management of selected young febrile infants without antibiotics - PubMed

For infants aged 29 to 60 days, a normal urinalysis and normal blood-based risk assessment identify a group at substantially lower risk of invasive bacterial infection in whom lumbar puncture, empiric antibiotics, and hospitalization may be avoided when follow-up is reliable. This is a risk-reduction strategy, not proof that bacterial meningitis is impossible. BMJDisparities and implicit bias in the management of low- risk febrile ...publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of Pediatrics

An abnormal urinalysis does not by itself establish meningitis, but it prevents simple designation as a low-risk febrile infant. Pair the urine result with blood culture and inflammatory markers when deciding whether cerebrospinal fluid testing and parenteral treatment are warranted. BMJDisparities and implicit bias in the management of low- risk febrile ...PubMedOutpatient management of selected young febrile infants without antibiotics - PubMed

Risk features that support escalation beyond screening tests. BMJApplication of Step-by-Step and Paediatric Emergency Care Applied Research Network (PECARN) Clinical Decision Aids in the management of young febrile infants in a UK cohort | Emergency Medicine JournalBMJDisparities and implicit bias in the management of low- risk febrile ...ScienceDirectEvaluation of the febrile infant younger than 3 months of age with no source of infection - ScienceDirectPubMedOutpatient management of selected young febrile infants without antibiotics - PubMed
FindingInterpretationNext action
Age younger than 28 daysOutpatient management is not recommended in the cited older outpatient framework. ScienceDirectEvaluation of the febrile infant younger than 3 months of age with no source of infection - ScienceDirectPerform hospital-based evaluation rather than using older-infant outpatient criteria. ScienceDirectEvaluation of the febrile infant younger than 3 months of age with no source of infection - ScienceDirect
Normal urinalysis and reassuring blood testing at 29-60 daysSubstantially lower invasive bacterial infection risk, but not zero. BMJDisparities and implicit bias in the management of low- risk febrile ...publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of PediatricsConsider deferring lumbar puncture only within an age-specific pathway and with reliable follow-up. BMJDisparities and implicit bias in the management of low- risk febrile ...
Abnormal urinalysis or inflammatory markerNo longer fits reassuring low-risk profile. publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of PediatricsPubMedOutpatient management of selected young febrile infants without antibiotics - PubMedEscalate bacterial evaluation; determine need for CSF testing, antibiotics, and admission from the complete risk profile. BMJDisparities and implicit bias in the management of low- risk febrile ...PubMedOutpatient management of selected young febrile infants without antibiotics - PubMed
Fever duration under 6 hoursEarly biomarkers can be falsely reassuring. BMJApplication of Step-by-Step and Paediatric Emergency Care Applied Research Network (PECARN) Clinical Decision Aids in the management of young febrile infants in a UK cohort | Emergency Medicine JournalObserve or use a lower escalation threshold. BMJApplication of Step-by-Step and Paediatric Emergency Care Applied Research Network (PECARN) Clinical Decision Aids in the management of young febrile infants in a UK cohort | Emergency Medicine Journal

Important modifier

Do not let a positive viral test replace bacterial testing

Viral positivity modifies pretest probability but does not eliminate coinfection.

Respiratory viral positivity is associated with lower prevalence of UTI, bacteremia, and meningitis in febrile young infants, but clinically important bacterial infection remains non-negligible. Continue age-appropriate urine and bacterial evaluation rather than using viral detection as a rule-out test. JAMAUrinary Tract Infection, Bacteremia, and Meningitis Among Febrile Young Infants With SARS-CoV-2 andJAMAPrevalence of Urinary Tract Infection, Bacteremia, and Meningitis Among Febrile Infants Aged 8 to 60 Days With

SARS-CoV-2-positive infants aged 8 to 60 days have lower prevalence of UTI, bacteremia, and meningitis than virus-negative infants, especially those aged 29 to 60 days with normal inflammatory markers. The most useful role of SARS-CoV-2 testing is therefore as a risk modifier after—not instead of—urinalysis and inflammatory-marker assessment. JAMAPrevalence of Urinary Tract Infection, Bacteremia, and Meningitis Among Febrile Infants Aged 8 to 60 Days With

For infants aged 61 to 90 days, respiratory viral infection is also associated with lower UTI prevalence; reported UTI rates among influenza-, RSV-, or SARS-CoV-2-positive infants were 2.2% to 5.2%. That residual rate supports continued urine-focused assessment when clinical evaluation indicates UTI risk. publications aapRisk of Bacterial Infections in Febrile Infants 61 to 90 Days Old With Respiratory Viruses | Pediatrics | American Academy of Pediatrics

How respiratory viral results should change—not replace—febrile-infant evaluation. JAMAUrinary Tract Infection, Bacteremia, and Meningitis Among Febrile Young Infants With SARS-CoV-2 andJAMAPrevalence of Urinary Tract Infection, Bacteremia, and Meningitis Among Febrile Infants Aged 8 to 60 Days Withpublications aapRisk of Bacterial Infections in Febrile Infants 61 to 90 Days Old With Respiratory Viruses | Pediatrics | American Academy of Pediatrics
Viral resultRisk interpretationPractical consequence
SARS-CoV-2 positive, 8-60 daysLower UTI, bacteremia, and meningitis prevalence than in SARS-CoV-2-negative infants. JAMAPrevalence of Urinary Tract Infection, Bacteremia, and Meningitis Among Febrile Infants Aged 8 to 60 Days WithContinue urine and inflammatory-marker assessment; use results with age to determine lumbar puncture and disposition. JAMAPrevalence of Urinary Tract Infection, Bacteremia, and Meningitis Among Febrile Infants Aged 8 to 60 Days With
Non-SARS-CoV-2 respiratory virus detectedLower but non-negligible UTI and invasive bacterial infection risk. JAMAUrinary Tract Infection, Bacteremia, and Meningitis Among Febrile Young Infants With SARS-CoV-2 andDo not omit bacterial evaluation solely because a respiratory virus is detected. JAMAUrinary Tract Infection, Bacteremia, and Meningitis Among Febrile Young Infants With SARS-CoV-2 and
Virus positive, 61-90 daysUTI prevalence remains 2.2%-5.2% for influenza, RSV, or SARS-CoV-2. publications aapRisk of Bacterial Infections in Febrile Infants 61 to 90 Days Old With Respiratory Viruses | Pediatrics | American Academy of PediatricsUse viral testing as a probability modifier, not a substitute for urine testing. publications aapRisk of Bacterial Infections in Febrile Infants 61 to 90 Days Old With Respiratory Viruses | Pediatrics | American Academy of Pediatrics

Disposition

Select outpatient management only after documented low-risk assessment and observation

Outpatient care is a structured disposition decision, not simply a negative initial screen.

Prospective outpatient management without lumbar puncture or antibiotics has been reported for selected infants older than 21 days who were well appearing, had no urine leukocytes, ANC 10,000/mm3 or lower, CRP 20 mg/L or lower, procalcitonin below 0.5 ng/mL, and no clinical deterioration during an emergency stay of less than 24 hours. Among 586 such infants managed as outpatients, two had serious bacterial infection and no patient returned with an invasive bacterial infection. PubMedOutpatient management of selected young febrile infants without antibiotics - PubMed

For U.S. practice, use the more stringent age-specific AAP-oriented framework for infants 29 to 60 days: normal urinalysis and reassuring inflammatory markers support avoiding lumbar puncture, empiric antibiotics, and hospitalization in selected patients, but the disposition requires reliable follow-up and a plan to act on culture results. BMJDisparities and implicit bias in the management of low- risk febrile ...publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of Pediatrics

Do not discharge based on normal early testing when the clinical trajectory is worsening. In the outpatient cohort, absence of deterioration during observation was an explicit low-risk requirement; in an external evaluation of Step-by-Step, an infant presenting within 6 hours of fever onset had normal urinalysis and biomarkers but Staphylococcus aureus bacteremia. BMJApplication of Step-by-Step and Paediatric Emergency Care Applied Research Network (PECARN) Clinical Decision Aids in the management of young febrile infants in a UK cohort | Emergency Medicine JournalPubMedOutpatient management of selected young febrile infants without antibiotics - PubMed

Disposition framework for well-appearing febrile infants. BMJApplication of Step-by-Step and Paediatric Emergency Care Applied Research Network (PECARN) Clinical Decision Aids in the management of young febrile infants in a UK cohort | Emergency Medicine JournalBMJDisparities and implicit bias in the management of low- risk febrile ...ScienceDirectEvaluation of the febrile infant younger than 3 months of age with no source of infection - ScienceDirectPubMedOutpatient management of selected young febrile infants without antibiotics - PubMed
Disposition optionSupported selection featuresReason to avoid this option
Hospital-based evaluationInfant younger than 28 days or otherwise outside low-risk outpatient criteria. ScienceDirectEvaluation of the febrile infant younger than 3 months of age with no source of infection - ScienceDirectDo not use older-infant outpatient criteria in this age group. ScienceDirectEvaluation of the febrile infant younger than 3 months of age with no source of infection - ScienceDirect
Potential outpatient management without lumbar puncture or antibioticsAge older than 21 days; well appearance; absent urine leukocytes; ANC 10,000/mm3 or lower; CRP 20 mg/L or lower; procalcitonin below 0.5 ng/mL; no deterioration during observation. PubMedOutpatient management of selected young febrile infants without antibiotics - PubMedAbnormal urine or biomarkers, clinical deterioration, or inability to complete observation excludes this profile. PubMedOutpatient management of selected young febrile infants without antibiotics - PubMed
Selected 29-60 day discharge under AAP-oriented risk stratificationNormal urinalysis and reassuring inflammatory markers identify substantially lower invasive bacterial infection risk. BMJDisparities and implicit bias in the management of low- risk febrile ...publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of PediatricsRisk remains nonzero; abnormal testing, evolving illness, or unreliable follow-up requires escalation. BMJDisparities and implicit bias in the management of low- risk febrile ...

Common questions

Can a positive SARS-CoV-2 test justify skipping urinalysis in a febrile infant?

No. SARS-CoV-2 positivity lowers the prevalence of UTI and invasive bacterial infection, particularly after 29 days with normal inflammatory markers, but does not eliminate bacterial coinfection; retain age-appropriate urine evaluation. JAMAUrinary Tract Infection, Bacteremia, and Meningitis Among Febrile Young Infants With SARS-CoV-2 andJAMAPrevalence of Urinary Tract Infection, Bacteremia, and Meningitis Among Febrile Infants Aged 8 to 60 Days With

What should be done when procalcitonin is unavailable?

Use the combined temperature, ANC, and CRP strategy: abnormal values are temperature greater than 38.5°C, ANC greater than 5,200/mm3, and CRP 20 mg/L or greater. Do not use a single marker alone to classify an infant low risk. publications aapGuideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of PediatricsacepAsk the Expert-Management of the Well-Appearing Febrile Young ...

References

  1. Urinary Tract Infection, Bacteremia, and Meningitis Among Febrile Young Infants With SARS-CoV-2 andjamanetwork.com · jamanetwork.com
  2. Prevalence of Urinary Tract Infection, Bacteremia, and Meningitis Among Febrile Infants Aged 8 to 60 Days Withjamanetwork.com · jamanetwork.com
  3. Viral bronchiolitis - The Lancetwww.thelancet.com · www.thelancet.com
  4. Application of Step-by-Step and Paediatric Emergency Care Applied Research Network (PECARN) Clinical Decision Aids in the management of young febrile infants in a UK cohort | Emergency Medicine Journalemj.bmj.com · emj.bmj.com
  5. Disparities and implicit bias in the management of low- risk febrile ...bmjopen.bmj.com · bmjopen.bmj.com
  6. Successful Outpatient Management of Febrile Infants Without a Lumbar Puncture or Antibiotics | NEJM Clinicianclinician.nejm.org · clinician.nejm.org
  7. SAEM25 Abstracts - 2025 - Academic Emergency Medicineonlinelibrary.wiley.com · onlinelibrary.wiley.com
  8. Risk of Meningitis in Infants Aged 29 to 90 Days with Urinary Tract Infection: A Systematic Review and Meta-Analysis - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  9. Risk of Urinary Tract Infection and Bacteremia in Infants... : Pediatric Emergency Carejournals.lww.com · journals.lww.com
  10. Frequency of serious bacterial infections in young infants with and without viral respiratory infections - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  11. Admit Versus Discharge—A Cost Analysis of Infants 29 to 60 Days Old With Febrile Urinary Tract Infection at Low Risk for Bacteremia - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  12. Abstracts of the European Academy of Paediatrics Congress and ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  13. Evaluation of the febrile infant younger than 3 months of age with no source of infection - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  14. Guideline-Based Risk Stratification for Febrile Young Infants Without Procalcitonin Measurement | Pediatrics | American Academy of Pediatricspublications.aap.org · publications.aap.org
  15. Rate of Urinary Tract Infections, Bacteremia, and Meningitis in Preterm and Term Infants | Pediatrics | American Academy of Pediatricspublications.aap.org · publications.aap.org
  16. Risk of Bacterial Infections in Febrile Infants 61 to 90 Days Old With Respiratory Viruses | Pediatrics | American Academy of Pediatricspublications.aap.org · publications.aap.org
  17. Investigating the Role of Staphylococcal Biofilms in the Pathogenesis of Pediatric Atopic Dermatitiswww.jacionline.org · www.jacionline.org
  18. Optimizing Management of Febrile Young Infants Without Serum ...publications.aap.org · publications.aap.org
  19. Use of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  20. Ask the Expert-Management of the Well-Appearing Febrile Young ...www.acep.org · www.acep.org
  21. Ask the Expert-Management of the Well-Appearing Febrile Young Infant: Integrating the AAP Guideline into Practice | Pediatric Emergency Medicineacep.org · acep.org
  22. Outpatient management of selected young febrile infants without antibiotics - PubMedwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  23. Oluwole YESCARTA in the outpatient setting. 05SEP23 1 of 74cdn.clinicaltrials.gov · cdn.clinicaltrials.gov
  24. [PDF] Preventing Adverse Incisional Outcomes at ... - ClinicalTrials.govcdn.clinicaltrials.gov · cdn.clinicaltrials.gov